|
|
Pituitary Neoplasms
Research News and Information
Definition of 'Pituitary Neoplasms'Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. |
Monday, November 23, 2009
Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx.
30 Oct 2009
Pseudoaneurysms are rare lesions with a multitude of causes, including infectious, traumatic, and iatrogenic origins. In addition, there are a number of potential treatment options, all of which require consideration to determine the most ... Read more...
30 Oct 2009
Somatostatin analogs (SSA) with their potent antisecretory and antiproliferative effects are the main medical treatment option for patients with neuroendocrine tumors, such as gastroenteropancreatic and acromegaly-associated growth hormone secreting ... Read more...
29 Sep 2009
The effects of TMG [2-(alpha-d-glucopyranosyl) methyl-2,5,7,8-tetramethylchroman-6-ol], a water-soluble vitamin E derivative, administered after irradiation on the mortality of X-irradiated mice and on the development of tumors in the mammary and ... Read more...
Latest indexed articles for 'Pituitary Neoplasms'
These are the very latest articles for this heading:
- Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx.
30 Oct 2009 - Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly.
30 Oct 2009 - Modification of mortality and tumorigenesis by tocopherol-mono-glucoside (TMG) administered after X irradiation in mice and rats.
29 Sep 2009 - The posterior petrosal approach: technique and applications in pediatric neurosurgery.
29 Sep 2009 - Modified orbitozygomatic craniotomy for craniopharyngioma resection in children.
29 Sep 2009 - Craniopharyngiomas in the posterior fossa: a rare subgroup, diagnosis, management and outcomes.
29 Sep 2009 - Images in clinical medicine. Cerebrospinal fluid leak.
29 Sep 2009 - [Treatment of pituitary adenomas]
25 Sep 2009 - [Cushing disease 30 years ago. Now noticeable brown skin pigment]
15 Sep 2009 - Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
2 Sep 2009 - Endoscopic approach for pituitary surgery improves rhinologic outcomes.
30 Aug 2009 - Ki-67 in pituitary neoplasms: a review--part I.
30 Aug 2009 - Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note.
30 Aug 2009 - Nonfunctioning pituitary adenomas: the Oxford experience.
30 Aug 2009 - Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation.
30 Aug 2009 - Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
30 Aug 2009 - Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas.
30 Aug 2009 - Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.
30 Aug 2009 - Pituitary surgery. Editorial.
30 Aug 2009 - Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study.
30 Aug 2009
See a longer list of these articles.
Technical information about 'Pituitary Neoplasms'
Definition: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
Descriptor UI: D010911
Alternative terms: Pituitary Neoplasms; Neoplasm, Pituitary; Neoplasms, Pituitary; Pituitary Neoplasm; Pituitary Tumors; Pituitary Tumor; Tumor, Pituitary; Tumors, Pituitary; Pituitary Adenoma; Adenoma, Pituitary; Adenomas, Pituitary; Pituitary Adenomas; Pituitary Carcinoma; Carcinoma, Pituitary; Carcinomas, Pituitary; Pituitary Carcinomas; Cancer of the Pituitary; Pituitary Cancer; Cancer, Pituitary; Cancers, Pituitary; Cancer of Pituitary; Pituitary Cancers;
Related Mesh Headings: Adenoma, Basophil; Adenoma, Chromophobe; Adenoma, Acidophil;
Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;
Tree Number: C04.588.322.609; C04.588.614.250.195.885.500.600; C10.228.140.211.885.500.600; C10.228.140.617.477.600; C10.228.140.617.738.675; C10.551.240.250.700.500.500; C19.344.609; C19.700.734;
Technical Notes: coordinate IM with histological type of neoplasm (IM); pituitary adenoma: coordinate IM with ADENOMA (IM) in spite of entry term PITUITARY ADENOMA